James R. Clark
Expertise in
2
conditions

Dr. James R. Clark

Internal Medicine
325 Winding River Lane, 
Charlottesville, VA 
Expertise in
2
conditions
325 Winding River Lane, 
Charlottesville, VA 

Overview

James Clark is a primary care provider, practicing in Internal Medicine in Charlottesville, Virginia.

Dr. Clark is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Familial Hemiplegic Migraine, Migraine with Brainstem Aura, Migraine, and Blood Clots.

He is actively involved in clinical research, co-authoring 3 peer reviewed articles and participating in 7 clinical trials.

Specialties

Internal Medicine

Licenses

Internal Medicine in FL

Fellowships

Cleveland Clinic - 1997
Cleveland Clinic Foundation - 1997

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 1 Less Insurance Carrier -

Locations

Charlottesville Medical Research Center, LLC
325 Winding River Lane, Charlottesville, VA 22911

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Vestibular Nerve Stimulation (VeNS), Together with a Lifestyle Modification Program, Compared to a Sham Control with a Lifestyle Modification Program, As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Vestibular Nerve Stimulation (VeNS), Together with a Lifestyle Modification Program, Compared to a Sham Control with a Lifestyle Modification Program, As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Behavioral, Device
Study Phase: Not Applicable
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Drug
Study Drug: X0002
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
An Open-Label, 12-Month Study to Evaluate the Safety and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: July 03, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
EMERGE: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Single Doses of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: June 29, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Randomized, Double-blind, Multi-center, Parallel-group, Dose-ranging Comparison of the Safety and Efficacy of the ZP-Zolmitriptan Intracutaneous Microneedle Systems to Placebo for the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: March 13, 2018
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
View 6 Less Clinical Trials

3 Total Publications

The acute effects of exercise intensity and inorganic nitrate supplementation on vascular health in females after menopause.
The acute effects of exercise intensity and inorganic nitrate supplementation on vascular health in females after menopause.
Journal: Journal of applied physiology (Bethesda, Md. : 1985)
Published: October 05, 2023
Similar Doctors
Expertise in
27
conditions
Dr. Curtis K. Argo
Internal Medicine
Expertise in
27
conditions
Dr. Curtis K. Argo
Internal Medicine

UVA Health Digestive Health Center

1215 Lee St, 
Charlottesville, VA 
 (2.4 miles away)
434-243-3090
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Curtis Argo is a primary care provider, practicing in Internal Medicine in Charlottesville, Virginia. Dr. Argo is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH), Hepatitis, Non-Alcoholic Fatty Liver Disease, Liver Transplant, and Endoscopy. Dr. Argo is currently accepting new patients.

Expertise in
19
conditions
Dr. Neeral L. Shah
Internal Medicine
Expertise in
19
conditions
Dr. Neeral L. Shah
Internal Medicine

UVA Health Digestive Health Center

1215 Lee St, 
Charlottesville, VA 
 (2.4 miles away)
434-243-3090
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Neeral Shah is a primary care provider, practicing in Internal Medicine in Charlottesville, Virginia. Dr. Shah is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Spontaneous Bacterial Peritonitis, Visceromegaly, Hepatitis, Liver Transplant, and Endoscopy. Dr. Shah is currently accepting new patients.

Expertise in
31
conditions
Dr. Lindsay D. Friesen
Internal Medicine
Expertise in
31
conditions
Dr. Lindsay D. Friesen
Internal Medicine

Sentara Blue Ridge Internal Medicine

2250 Ivy Road, Suite 200, 
Charlottesville, VA 
 (3.5 miles away)
434-654-4550
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Lindsay Friesen is a primary care provider, practicing in Internal Medicine in Charlottesville, Virginia. Dr. Friesen is highly rated in 31 conditions, according to our data. Her clinical expertise encompasses Cirrhosis, Familial Combined Hyperlipidemia, Xanthoma, and High Cholesterol. Dr. Friesen is board certified in American Board Of Internal Medicine - Internal Medicine - 2027. Dr. Friesen is currently accepting new patients.

Frequently Asked Questions about Dr. James R. Clark

How do I make an appointment with Dr. James R. Clark?

You can book an appointment with Dr. James R. Clark by calling their office at 434-817-2442. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. James R. Clark a top-rated expert for Familial Hemiplegic Migraine?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. James R. Clark is classified as an Advanced expert for Familial Hemiplegic Migraine, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. James R. Clark specialize in?

While Dr. James R. Clark is a Internal Medicine, they have specific expertise in Familial Hemiplegic Migraine, Migraine with Brainstem Aura, and Migraine. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. James R. Clark participate in research or clinical trials?

Yes. Dr. James R. Clark has published 3 articles and abstracts on conditions like Familial Hemiplegic Migraine. You can view a list of Dr. James R. Clark's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. James R. Clark accept my insurance?

Dr. James R. Clark accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 434-817-2442 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Clark's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile